Document Detail


Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.
MedLine Citation:
PMID:  18062409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The in vivo metabolism of the antipsychotic agent mazapertine was studied after oral administration of mazapertine succinate (40 mg/subject) to two healthy volunteers, and urine (0-24 hours) was obtained for metabolite identification using API-ionspray LC/MS and MS/MS analysis. Unchanged mazapertine (12% of the sample) plus 10 metabolites were profiled, quantified, and tentatively identified on the basis of MS data, Glusulase-hydrolysis, and by comparison to synthetic samples. The formation of mazapertine metabolites are via seven metabolic pathways: (1) phenylhydroxylation, (2) piperidyl oxidation, (3) O-dealkylation, (4) N-dephenylation, (5) oxidative N-debenzylation, (6). depiperidylation, and (7) glucuronidation. Pathways 1, 2, 5 and 7 formed 4-OH-phenyl-mazapertine (M1, 18%) and 4-OH-piperidyl (M2, 14%)-mazapertine, carboxybenzoylpiperidine (M8, 10%) and its glucuronide (M9, 14%) as four major metabolites. Six moderate and minor metabolites (M3-M7 & M10; each < or =10%) formed via a combination of pathways 1-6. Mazapertine is extensively metabolized in humans.
Authors:
Wu-Nan Wu; Linda A McKown; Allen B Reitz
Related Documents :
3970719 - Excretion pattern and metabolism of hexachlorobutadiene in rats. evidence for metabolic...
3780069 - Triamterene-induced crystalluria and cylinduria: clinical and experimental studies.
7349329 - Three compartment model for pyrimethamine disposition in the pig.
7721229 - Mice plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydrox...
16863459 - Donepezil: a review.
2240799 - Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and ex...
959319 - Assessment of methodology in single-dose studies of digoxin bioavailability.
7778709 - Acute gamekeeper's thumb. quantitative outcome of surgical repair.
12404549 - Sex differences in estimation of time intervals and in reaction time are removed by mod...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of drug metabolism and pharmacokinetics     Volume:  32     ISSN:  0378-7966     ISO Abbreviation:  Eur J Drug Metab Pharmacokinet     Publication Date:    2007 Jul-Sep
Date Detail:
Created Date:  2007-12-07     Completed Date:  2007-12-27     Revised Date:  2011-02-02    
Medline Journal Info:
Nlm Unique ID:  7608491     Medline TA:  Eur J Drug Metab Pharmacokinet     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  171-6     Citation Subset:  IM    
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, Spring House, PA 19477, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Antipsychotic Agents / administration & dosage,  metabolism*,  pharmacokinetics,  urine*
Humans
Piperazines / administration & dosage,  metabolism*,  pharmacokinetics,  urine*
Spectrometry, Mass, Electrospray Ionization
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Piperazines; 134208-18-7/mazapertine succinate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects.
Next Document:  Releasing characteristics of phosphorus and other substances during thermal treatment of excess slud...